Funding · Company
Ollin Biosciences, Inc.
Austin, TXBiotech & Pharma
Ollin Biosciences, Inc. of Austin, TX has disclosed $156M across 1 Form D offering filed with the SEC on Jun 24, 2026.
$156M
Total disclosed
1
Form D offering
2022
Incorporated
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$156M
Form D · Jun 24, 2026 ↗
Q2 2026
· target $330M
Filing details
HeadquartersAustin, TXIndustryBiotech & Pharma (Biotechnology)Incorporated2022SEC CIK0002141184Offerings on file1
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →